Colgate-Palmolive Announces 3rd Quarter 2026 Results
• Net sales increased 4.6%; Organic sales* increased 3.6%, including a 0.2% negative impact from lower private label pet food sales
• GAAP Gross profit margin increased 80 basis points to 60.2%; Base Business Gross profit margin* increased 90 basis points to 60.3%
• Net cash provided by operations was $2,913 million for the first nine months of 2026
• The Company’s leadership in toothpaste continued with its global market share at 41.4% year to date
• The Company’s leadership in manual toothbrushes continued with its global market share at 33.1% year to date
• The Company narrowed its sales guidance and raised its gross profit margin and Base Business earnings per share guidance for full year 2026
Third Quarter Total Company Results (GAAP) ($ in millions except per share 2026 2025 Change amounts) Net Sales $5,369 $5,131 +4.6 % EPS (diluted) $0.94 $0.91 +3 % Third Quarter Total Company Results (Base Business - Non-GAAP)* 2026 2025 Change Organic Sales Growth +3.6 % Base Business EPS (diluted) $0.97 $0.91 +7 %
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
…Colgate-Palmolive Company (NYSE:CL) today reported results for third quarter 2026. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business third quarter results, “Our growth momentum continued, delivering another strong quarter of broad-based top- and bottom-line growth with net sales and organic sales increasing in all four categories and in four of five divisions. We were particularly pleased to have delivered our fourth quarter of sequential improvement in worldwide volume growth, while delivering strong pricing growth in the third quarter. As was the case last quarter, gross profit, gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increased year over year.
“We remain focused on executing our 2030 strategy, with an emphasis on driving premium, science-based innovation, and we continue to invest behind our brands globally supported by another double-digit increase in advertising this quarter.
“Despite consumer uncertainty and ongoing macroeconomic volatility, our proactive focus on driving growth while building flexibility into our P&L gives us confidence we can navigate these challenges while continuing to deliver consistent, compounded earnings per share growth and drive long-term shareholder value.”
• The Company now expects net sales to be up 4% to 5% (versus 2% to 6% previously), including a low-single-digit positive impact from foreign exchange.
• The Company now expects organic sales growth to be broadly in line with its nine-month performance (versus 1% to 4% previously). This includes the impact from our exit from the private label pet food business.
• On a GAAP basis, the Company now expects gross profit margin to be up (versus roughly flat previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth.
• On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be up (versus roughly flat previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales; it also now expects 5% to 7% earnings per share growth (versus mid-single-digit growth previously).
See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. Recast historical geographic segment information can be found on the Company's website.
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
At approximately 7:00 a.m. ET today, the Company will post its prepared materials regarding third quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.
At 8:30 a.m. ET today, the Company will host a conference call regarding third quarter results. To access this call as a webcast, please go to Colgate- Palmolive’s website at www.colgatepalmolive.com.
Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill’s Prescription Diet, Hill’s Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom’s of Maine. We are recognized for our leadership and innovation in promoting community wellbeing and improving children’s oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991. For more information about Colgate-Palmolive and how we make more smiles, visit www.colgatepalmolive.com. CL-E
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third- party vendors, primarily Nielsen, and internal estimates. Except as otherwise noted, all market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.
This press release and the related prepared materials and webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management ’ s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, category growth rates, the impact of foreign exchange, the impact of developments in global trade relations and tariffs, the impact of geopolitical events and tensions, wars and military conflicts, such as in Ukraine and the Middle East, cost reduction plans (including the Strategic Growth and Productivity Program), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company ’ s views and assumptions as of October 30, 2026. The Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company ’ s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company ’ s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company ’ s Investor Relations Department or on the Company ’ s website at www.colgatepalmolive.com.
The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:
• Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to the Strategic Growth and Productivity Program and the ERISA litigation matter and acquisition-related costs.
• Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
• Free cash flow before dividends: Net cash provided by operations less Capital expenditures.
This press release and the related prepared materials and webcast discuss Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company ’ s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and nine months ended September 30, 2026 versus 2025 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.
Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to- period financial results. See “ Non-GAAP Reconciliations” for the three and nine months ended September 30, 2026 and 2025 included with this release for a reconciliation of these financial measures to the related GAAP measures.
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company ’ s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
As management uses free cash flow before dividends to evaluate the Company ’ s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “ Condensed Consolidated Statements of Cash Flows ” for the nine months ended September 30, 2026 and 2025 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP. (See attached tables for third quarter results.)
Colgate-Palmolive Company Condensed Consolidated Statements of Income For the Three Months Ended September 30, 2026 and 2025 (Dollars in Millions Except Per Share Amounts) (Unaudited) Net sales Cost of sales Gross profit Gross profit margin Selling, general and administrative expenses Other (income) expense, net 5,369 5,131 Operating profit 2,136 2,082 Operating profit margin 3,233 3,049 Non-service related postretirement 60.2 59.4 costs 2,111 1,971 Interest expense 34 19 Interest income 1,088 1,059 Income before income taxes 20.3 20.6 Provision for income taxes 24 21 Effective tax rate 62 67 Net income including 17 21 noncontrolling interests 1,019 992 Less: Net income attributable to 240 226 noncontrolling interests 23.6 22.8 Table 1 Net income attributable to 779 % 766 % Colgate-Palmolive Company 28 % 31 % Earnings per common share 2026 751 % 2025 735 % ────────────────────────────────────────────────────────────────────────────── Basic $ 0.94 $ 0.91 Diluted $ 0.94 $ 0.91 Supplemental Income Statement Information Average common shares outstanding Basic 796.9 807.8 Diluted 799.7 810.2 Advertising $ 775 $ 674
Colgate-Palmolive Company Condensed Consolidated Statements of Income For the Nine Months Ended September 30, 2026 and 2025 (Dollars in Millions Except Per Share Amounts) (Unaudited) Net sales Cost of sales Gross profit Gross profit margin Selling, general and administrative expenses Other (income) expense, net 16,055 15,152 Operating profit 6,300 6,047 Operating profit margin 9,755 9,105 Non-service related 60.8 60.1 postretirement costs 6,316 5,833 Interest expense 370 58 Interest income 3,069 3,214 Income before income taxes 19.1 21.2 Provision for income taxes 70 116 Effective tax rate 186 203 Net income including 50 56 noncontrolling interests 2,863 2,951 Less: Net income attributable to 682 685 noncontrolling interests 23.8 23.2 Table 2 Net income attributable to 2,181 % 2,266 % Colgate-Palmolive Company 91 % 97 % Earnings per common share 2026 2,090 % 2025 2,169 % ────────────────────────────────────────────────────────────────────────────── Basic(1) $ 2.61 $ 2.68 Diluted(1) $ 2.61 $ 2.67 Supplemental Income Statement Information Average common shares outstanding Basic 799.5 810.0 Diluted 802.2 812.8 Advertising $ 2,286 $ 2,020 Note: (1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.
(1) Marketable securities of $85 , $107 and $193 as of September 30, 2026, December 31, 2025 and September 30, 2025, respectively, are included in Other current assets.
Colgate-Palmolive Company Condensed Consolidated Statements of Cash Flows For the Nine Months Ended September 30, 2026 and 2025 (Dollars in Millions) (Unaudited) Operating Activities 2026 2025 Table 4 ────────────────────────────────────────────────────────────────────────────── Net income including noncontrolling $ 2,181 $ 2,266 interests Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: Depreciation and amortization 470 457 ERISA litigation matter — 65 Restructuring and termination benefits, 177 -15 net of cash Stock-based compensation expense 141 127 Deferred income taxes 54 8 Cash effects of changes in: Receivables -224 -180 Inventories -104 9 Accounts payable and other working 254 30 capital Other non-current assets 48 48 Other non-current liabilities -84 -70 Net cash provided by (used in) 2,913 2,745 operations Investing Activities Capital expenditures -400 -387 Purchases of marketable securities and -163 -537 investments Proceeds from sale of marketable 187 508 securities and investments Payment for acquisition, net of cash — -293 acquired Other investing activities -5 -5 Net cash provided by (used in) investing -381 -714 activities Financing Activities Short-term borrowing (repayment) less 947 139 than 90 days, net Principal payments on debt -1,087 -655 Proceeds from issuance of debt — 497 Dividends paid -1,308 -1,300 Purchases of treasury shares -927 -804 Proceeds from exercise of stock 178 83 options Other financing activities -75 145 Net cash provided by (used in) financing -2,272 -1,895 activities Effect of exchange rate changes on Cash -21 47 and cash equivalents Net increase (decrease) in Cash and cash 239 183 equivalents Cash and cash equivalents at beginning 1,288 1,096 of the period Cash and cash equivalents at end of the $ 1,527 $ 1,279 period Supplemental Cash Flow Information Free cash flow before dividends (Net cash provided by operations less Capital expenditures) Net cash provided by operations $ 2,913 $ 2,745 Less: Capital expenditures -400 -387 Free cash flow before dividends $ 2,513 $ 2,358 Income taxes paid $ 648 $ 712 Interest paid $ 205 $ 235
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.
(2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.
Corporate Operating profit (loss) for the three and nine months ended September 30, 2026 included charges resulting from the Strategic Growth and Productivity Program of $29 and $327, respectively.
Corporate Operating profit (loss) for the nine months ended September 30, 2025 included charges resulting from the ERISA litigation matter of $15 and acquisition-related costs of $9.
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.
(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the Middle East and Eastern and Central Europe.
(1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.2%, 0.8% and 0.3% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.
(2) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026.
(3) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the Middle East and Eastern and Central Europe.
Table 8 Colgate-Pa… Company Non-GAAP Reconcilia… For the Three Months Ended September 30, 2026 and 2025 (Dollars in Millions Except Per Share Amounts) (Unaudited) Gross 2026 2025 Profit Gross profit, $ 3,233 $ 3,049 GAAP Strategic Growth and 5 — Productivi… Program Gross profit, $ 3,238 $ 3,049 non-GAAP Basis Point Gross Profit 2026 2025 Change Margin Gross profit 60.2 % 59.4 % 80 margin, GAAP Strategic Growth and 0.1 % — % Productivi… Program Gross profit 60.3 % 59.4 % 90 margin, non-GAAP Selling, General and 2026 2025 Administra… Expenses Selling, general and administra… $ 2,111 $ 1,971 expenses, GAAP Strategic Growth and -9 — Productivi… Program Selling, general and administra… $ 2,102 $ 1,971 expenses, non-GAAP Basis Point Selling, General and Administra… Expenses as 2026 2025 Change a Percentage of Net Sales Selling, general and administra… expenses as a 39.3 % 38.4 % 90 percentage of Net sales, GAAP Strategic Growth and -0.2 % — % Productivi… Program Selling, general and administra… expenses as a 39.1 % 38.4 % 70 percentage of Net sales, non-GAAP Other (Income) 2026 2025 Expense, Net Other (income) $ 34 $ 19 expense, net, GAAP Strategic Growth and -15 — Productivi… Program Other (income) expense, $ 19 $ 19 net, non-GAAP Operating 2026 2025 % Change Profit Operating profit, $ 1,088 $ 1,059 3 % GAAP Strategic Growth and 29 — Productivi… Program Operating profit, $ 1,117 $ 1,059 5 % non-GAAP Basis Point Operating Profit 2026 2025 Change Margin Operating profit 20.3 % 20.6 % -30 margin, GAAP Strategic Growth and 0.5 % — % Productivi… Program Operating profit 20.8 % 20.6 % 20 margin, non-GAAP Non-Service Related 2026 2025 Postretire… Costs Non-service related $ 24 $ 21 postretire… costs, GAAP Strategic Growth and -1 — Productivi… Program Non-service related postretire… $ 23 $ 21 costs, non-GAAP Note: The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non- GAAP adjustment on Income before income taxes and Provision for income taxes.
Table 9 Colgate-P… Company Non-GAAP Reconcili… For the Nine Months Ended September 30, 2026 and 2025 (Dollars in Millions Except Per Share Amounts) (Unaudite… Gross 2026 2025 Profit Gross profit, $ 9,755 $ 9,105 GAAP Strategic Growth and 7 — Productiv… Program Gross profit, $ 9,762 $ 9,105 non-GAAP Selling, General and 2026 2025 Administr… Expenses Selling, general and $ 6,316 $ 5,833 administr… expenses, GAAP Strategic Growth and -20 — Productiv… Program ERISA litigation — -15 matter Selling, general and $ 6,296 $ 5,817 administr… expenses, non-GAAP Basis Point Selling, General and Administr… Expenses 2026 2025 Change as a Percentage of Net Sales Selling, general and administr… expenses 39.3 % 38.5 % 80 as a percentage of Net sales, GAAP Strategic Growth and -0.1 % — % Productiv… Program ERISA litigation — % -0.1 % matter Selling, general and administr… expenses 39.2 % 38.4 % 80 as a percentage of Net sales, non-GAAP Other (Income) 2026 2025 Expense, Net Other (income) $ 370 $ 58 expense, net, GAAP Strategic Growth and -300 — Productiv… Program Acquisiti… — -9 costs Other (income) expense, $ 70 $ 48 net, non-GAAP Operating 2026 2025 % Change Profit Operating profit, $ 3,069 $ 3,214 -5 % GAAP Strategic Growth and 327 — Productiv… Program ERISA litigation — 15 matter Acquisiti… — 9 costs Operating profit, $ 3,396 $ 3,240 5 % non-GAAP Basis Point Operating Profit 2026 2025 Change Margin Operating profit 19.1 % 21.2 % -210 margin, GAAP Strategic Growth and 2.1 % — % Productiv… Program ERISA litigation — % 0.1 % matter Acquisiti… — % 0.1 % costs Operating profit 21.2 % 21.4 % -20 margin, non-GAAP Non-Servi… Related 2026 2025 Postretir… Costs Non-servi… related postretir… $ 70 $ 116 costs, GAAP Strategic Growth and -6 — Productiv… Program ERISA litigation — -50 matter Non-servi… related postretir… $ 64 $ 66 costs, non-GAAP Note: The impact of non-GAAP adjustmen… may not necessari… equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non- GAAP adjustment on Income before income taxes and Provision for income taxes.
Full text with the tables
Exhibit 99
Colgate-Palmolive Announces 3rd Quarter 2026 Results
• Net sales increased 4.6%; Organic sales* increased 3.6%, including a 0.2%
negative impact from lower private label pet food sales
• GAAP EPS increased 3% to $0.94; Base Business EPS* increased 7% to $0.97
• GAAP Gross profit margin increased 80 basis points to 60.2%; Base Business
Gross profit margin* increased 90 basis points to 60.3%
• Net cash provided by operations was $2,913 million for the first nine months
of 2026
• The Company’s leadership in toothpaste continued with its global market share
at 41.4% year to date
• The Company’s leadership in manual toothbrushes continued with its global
market share at 33.1% year to date
• The Company narrowed its sales guidance and raised its gross profit margin and
Base Business earnings per share guidance for full year 2026
Third Quarter Total Company Results
(GAAP)
($ in millions except per share 2026 2025 Change
amounts)
Net Sales $5,369 $5,131 +4.6 %
EPS (diluted) $0.94 $0.91 +3 %
Third Quarter Total Company Results
(Base Business - Non-GAAP)*
2026 2025 Change
Organic Sales Growth +3.6 %
Base Business EPS (diluted) $0.97 $0.91 +7 %
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial
Measures” later in this release for definitions of non-GAAP financial measures
and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 -
Non-GAAP Reconciliations” included with this release for a reconciliation of
these non-GAAP financial measures to the related GAAP measures.
New York, New York, October 30, 2026
…Colgate-Palmolive Company (NYSE:CL) today reported results for third quarter
2026. Noel Wallace, Chairman, President and Chief Executive Officer, commented
on the Base Business third quarter results, “Our growth momentum continued,
delivering another strong quarter of broad-based top- and bottom-line growth
with net sales and organic sales increasing in all four categories and in four
of five divisions. We were particularly pleased to have delivered our fourth
quarter of sequential improvement in worldwide volume growth, while delivering
strong pricing growth in the third quarter. As was the case last quarter, gross
profit, gross profit margin, operating profit, operating profit margin, net
income, earnings per share and free cash flow all increased year over year.
“We remain focused on executing our 2030 strategy, with an emphasis on driving
premium, science-based innovation, and we continue to invest behind our brands
globally supported by another double-digit increase in advertising this quarter.
“Despite consumer uncertainty and ongoing macroeconomic volatility, our
proactive focus on driving growth while building flexibility into our P&L gives
us confidence we can navigate these challenges while continuing to deliver
consistent, compounded earnings per share growth and drive long-term shareholder
value.”
Full Year 2026 Guidance
Based on current spot rates:
• The Company now expects net sales to be up 4% to 5% (versus 2% to 6%
previously), including a low-single-digit positive impact from foreign exchange.
• The Company now expects organic sales growth to be broadly in line with its
nine-month performance (versus 1% to 4% previously). This includes the impact
from our exit from the private label pet food business.
• On a GAAP basis, the Company now expects gross profit margin to be up (versus
roughly flat previously) and still expects advertising to be up on both a dollar
basis and as a percentage of net sales and double-digit earnings per share
growth.
• On a non-GAAP (Base Business) basis, the Company now expects gross profit
margin to be up (versus roughly flat previously) and still expects advertising
to be up on both a dollar basis and as a percentage of net sales; it also now
expects 5% to 7% earnings per share growth (versus mid-single-digit growth
previously).
Divisional Performance
See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table
5 - Segment Information" for additional information on net sales and operating
profit by division.
Third
Quarter
Sales
Growth By
Division
(% change
3Q 2026
vs. 3Q
2025
except %
of Total
Company
Sales)
% of Total Net Organic
Company Sales Sales* Volume Pricing FX
Sales
North 17% -1.7% -1.6% -3.7% +2.2% -0.2%
America(1)
Latin 25% +12.5% +6.0% +3.9% +2.1% +6.5%
America
Europe,
Middle 21% +1.4% +2.7% +3.5% -0.9% -1.2%
East &
Africa(1)
Asia 15% +3.5% +4.6% +1.9% +2.8% -1.1%
Pacific(1)
Hill’s Pet 22% +5.6% +5.7% +1.8% +3.9% -0.1%
Nutrition
Total 100% +4.6% +3.6% +1.7% +2.0% +1.0%
Company
Table may not sum due to rounding.
(1) The Company has recast its historical geographic segment information to
conform to the reporting structure effective for the quarter ended March 31,
2026. Recast historical geographic segment information can be found on the
Company's website.
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial
Measures” later in this release for definitions of non-GAAP financial measures
and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with
this release for a reconciliation of these non-GAAP financial measures to the
related GAAP measures.
Third Quarter
Operating
Profit By
Division
($ in
millions)
Change in
% Change vs basis points
3Q 2026 3Q 2025 % to Net Sales vs 3Q 2025
% to Net
Sales
North $177 -11% 19.5% -210
America(1)
Latin America $392 17% 29.6% +100
Europe,
Middle East & $262 8% 23.2% +140
Africa(1)
Asia $211 -1% 26.4% -110
Pacific(1)
Hill’s Pet $267 5% 22.2% -20
Nutrition
Total
Company, As $1,088 3% 20.3% -30
Reported
Total
Company, Base $1,117 5% 20.8% +20
Business*
(1) The Company has recast its historical geographic segment information to
conform to the reporting structure effective for the quarter ended March 31,
2026.
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial
Measures” later in this release for definitions of non-GAAP financial measures
and to “Table 8 - Non-GAAP Reconciliations” included with this release for a
reconciliation of these non-GAAP financial measures to the related GAAP
measures.
Prepared Materials and Webcast Information
At approximately 7:00 a.m. ET today, the Company will post its prepared
materials regarding third quarter results to the Investor Center section of its
website at https://investor.colgatepalmolive.com/events-and-presentations.
At 8:30 a.m. ET today, the Company will host a conference call regarding third
quarter results. To access this call as a webcast, please go to Colgate-
Palmolive’s website at www.colgatepalmolive.com.
About Colgate-Palmolive
Colgate-Palmolive Company is a caring, innovative growth company that is
reimagining a healthier future for all people, their pets and our planet.
Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our
products in more than 200 countries and territories under brands such as
Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga,
hello, Hill’s Prescription Diet, Hill’s Science Diet, Irish Spring, Lady Speed
Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline,
Speed Stick, Suavitel and Tom’s of Maine. We are recognized for our leadership
and innovation in promoting community wellbeing and improving children’s oral
health through our Colgate Bright Smiles, Bright Futures program, which has
reached approximately two billion children and their families since 1991. For
more information about Colgate-Palmolive and how we make more smiles, visit
www.colgatepalmolive.com. CL-E
Market Share Information
Management uses market share information as a key indicator to monitor business
health and performance. References to market share in this press release are
based on a combination of consumption and market share data provided by third-
party vendors, primarily Nielsen, and internal estimates. Except as otherwise
noted, all market share references represent the percentage of the dollar value
of sales of our products, relative to all product sales in the category in the
countries in which the Company competes and purchases data (excluding Venezuela
from all periods).
Market share data is subject to limitations on the availability of up-to-date
information. In particular, market share data is currently not generally
available for certain retail channels, such as eCommerce and certain club
retailers and discounters. The Company measures year-to-date market shares from
January 1 of the relevant year through the most recent period for which market
share data is available, which typically reflects a lag time of one or two
months. The Company believes that the third-party vendors it uses to provide
data are reliable, but it has not verified the accuracy or completeness of the
data or any assumptions underlying the data. In addition, market share
information reported by the Company may be different from market share
information reported by other companies due to differences in category
definitions, the use of data from different countries, internal estimates and
other factors.
Cautionary Statement on Forward-Looking Statements
This press release and the related prepared materials and webcast may contain
forward-looking statements (as that term is defined in the U.S. Private
Securities Litigation Reform Act of 1995 or by the Securities and Exchange
Commission (SEC) in its rules, regulations and releases) that set forth
anticipated results based on management ’ s current plans and assumptions. Such
statements may relate, for example, to sales or volume growth, net selling price
increases, organic sales growth, profit or profit margin levels, earnings per
share levels, financial goals, category growth rates, the impact of foreign
exchange, the impact of developments in global trade relations and tariffs, the
impact of geopolitical events and tensions, wars and military conflicts, such as
in Ukraine and the Middle East, cost reduction plans (including the Strategic
Growth and Productivity Program), tax rates, interest rates, new product
introductions, digital capabilities, commercial investment levels, acquisitions,
divestitures, share repurchases or legal or tax proceedings, among other
matters. These statements are made on the basis of the Company ’ s views and
assumptions as of October 30, 2026. The Company undertakes no obligation to
update these statements whether as a result of new information, future events or
otherwise, except as required by law or by the rules and regulations of the SEC.
Moreover, the Company does not, nor does any other person, assume responsibility
for the accuracy and completeness of these statements. The Company cautions
investors that any such forward-looking statements are not guarantees of future
performance and that actual events or results may differ materially from those
statements. For more information about factors that could impact the Company ’ s
business and cause actual results to differ materially from forward-looking
statements, investors should refer to the Company ’ s filings with the SEC
(including, but not limited to, the information set forth under the captions
“Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the
Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and
subsequent filings with the SEC). Copies of these filings may be obtained upon
request from the Company ’ s Investor Relations Department or on the Company ’ s
website at www.colgatepalmolive.com.
Non-GAAP Financial Measures
The following provides definitions and other information regarding the non-GAAP
financial measures used in this press release and the related prepared materials
and webcast, which may not be the same as or comparable to similar measures
presented by other companies:
• Base Business: Base Business refers to non-GAAP measures of operating results
that exclude certain items. Base Business operating results exclude, as
applicable, charges related to the Strategic Growth and Productivity Program and
the ERISA litigation matter and acquisition-related costs.
• Organic sales growth: Net sales growth excluding the impact of foreign
exchange, acquisitions and divestments.
• Free cash flow before dividends: Net cash provided by operations less Capital
expenditures.
This press release and the related prepared materials and webcast discuss Net
sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the
organic sales growth measure provides investors and analysts with useful
supplemental information regarding the Company ’ s underlying sales trends by
presenting sales growth excluding the external factor of foreign exchange as
well as the impact from acquisitions and divestments. See “Geographic Sales
Analysis Percentage Changes” for the three and nine months ended September 30,
2026 versus 2025 included with this release for a comparison of Organic sales
growth to Net sales growth in accordance with GAAP.
Gross profit, Gross profit margin, Selling, general and administrative expenses,
Selling, general and administrative expenses as a percentage of Net sales, Other
(income) expense, net, Operating profit, Operating profit margin, Non-service
related postretirement costs, Effective income tax rate, Net income attributable
to Colgate-Palmolive Company and Diluted earnings per common share are disclosed
on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP
financial measures exclude items that, either by their nature or amount,
management would not expect to occur as part of the Company’s normal business on
a regular basis, such as restructuring charges, charges for certain litigation
and tax matters, acquisition-related costs, gains and losses from certain
divestitures and certain other unusual, non-recurring items. Investors and
analysts use these financial measures in assessing the Company’s business
performance, and management believes that presenting these financial measures on
a non-GAAP basis provides them with useful supplemental information to enhance
their understanding of the Company’s underlying business performance and trends.
These non-GAAP financial measures also enhance the ability to compare period-to-
period financial results. See “ Non-GAAP Reconciliations” for the three and nine
months ended September 30, 2026 and 2025 included with this release for a
reconciliation of these financial measures to the related GAAP measures.
The Company uses these financial measures internally in its budgeting process,
to evaluate segment and overall operating performance and as factors in
determining compensation. While the Company believes that these financial
measures are useful in evaluating the Company ’ s underlying business
performance and trends, this information should be considered as supplemental in
nature and is not meant to be considered in isolation or as a substitute for the
related financial information prepared in accordance with GAAP.
As management uses free cash flow before dividends to evaluate the Company ’ s
ability to satisfy current and future obligations, pay dividends, fund future
business opportunities and repurchase stock, the Company believes that it
provides useful information to investors. Free cash flow before dividends is not
a measure of cash available for discretionary expenditures since the Company has
certain non-discretionary obligations such as debt service that are not deducted
from the measure. See “ Condensed Consolidated Statements of Cash Flows ” for
the nine months ended September 30, 2026 and 2025 for a comparison of free cash
flow before dividends to Net cash provided by operations as reported in
accordance with GAAP.
(See attached tables for third quarter results.)
Contacts
Investor Relations: investor_relations@colpal.com
Communications: colgate_palmolive_media_inquiry@colpal.com
Colgate-Palmolive Company
Condensed Consolidated Statements
of Income
For the Three Months Ended
September 30, 2026 and 2025
(Dollars in Millions Except Per
Share Amounts) (Unaudited)
Net sales
Cost of sales
Gross profit
Gross profit margin
Selling, general and
administrative expenses
Other (income) expense, net 5,369 5,131
Operating profit 2,136 2,082
Operating profit margin 3,233 3,049
Non-service related postretirement 60.2 59.4
costs 2,111 1,971
Interest expense 34 19
Interest income 1,088 1,059
Income before income taxes 20.3 20.6
Provision for income taxes 24 21
Effective tax rate 62 67
Net income including 17 21
noncontrolling interests 1,019 992
Less: Net income attributable to 240 226
noncontrolling interests 23.6 22.8 Table 1
Net income attributable to 779 % 766 %
Colgate-Palmolive Company 28 % 31 %
Earnings per common share 2026 751 % 2025 735 %
──────────────────────────────────────────────────────────────────────────────
Basic $ 0.94 $ 0.91
Diluted $ 0.94 $ 0.91
Supplemental Income Statement
Information
Average common shares outstanding
Basic 796.9 807.8
Diluted 799.7 810.2
Advertising $ 775 $ 674
Colgate-Palmolive Company
Condensed Consolidated
Statements of Income
For the Nine Months Ended
September 30, 2026 and 2025
(Dollars in Millions Except Per
Share Amounts) (Unaudited)
Net sales
Cost of sales
Gross profit
Gross profit margin
Selling, general and
administrative expenses
Other (income) expense, net 16,055 15,152
Operating profit 6,300 6,047
Operating profit margin 9,755 9,105
Non-service related 60.8 60.1
postretirement costs 6,316 5,833
Interest expense 370 58
Interest income 3,069 3,214
Income before income taxes 19.1 21.2
Provision for income taxes 70 116
Effective tax rate 186 203
Net income including 50 56
noncontrolling interests 2,863 2,951
Less: Net income attributable to 682 685
noncontrolling interests 23.8 23.2 Table 2
Net income attributable to 2,181 % 2,266 %
Colgate-Palmolive Company 91 % 97 %
Earnings per common share 2026 2,090 % 2025 2,169 %
──────────────────────────────────────────────────────────────────────────────
Basic(1) $ 2.61 $ 2.68
Diluted(1) $ 2.61 $ 2.67
Supplemental Income Statement
Information
Average common shares
outstanding
Basic 799.5 810.0
Diluted 802.2 812.8
Advertising $ 2,286 $ 2,020
Note:
(1) Basic and diluted earnings
per share are computed
independently for each quarter
and any year-to-date period
presented. As a result of
changes in shares outstanding
during the year and rounding,
the sum of the quarters'
earnings per share may not equal
the earnings per share for any
year-to-date period.
Colga…
Compa…
Conde…
Conso…
Balan…
Sheets
As of
Septe…
30,
2026,
Decem…
31,
2025
and
Septe…
30,
2025
(Doll…
in
Milli…
(Unau…
Cash
and
cash
equiv…
Recei…
net
Inven…
Other
curre…
assets
Prope…
plant
and
equip…
net
Goodw…
Other
intan…
asset…
net
Other
assets
Total
assets
Total
debt
Other
curre…
liabi…
Other
non-c…
liabi…
Total
liabi… 1,527 1,288 1,279
Total 1,901 1,675 1,807
Colga… 2,182 2,032 2,109
Compa… 747 714 844
share… 4,613 4,660 4,560
equity 3,080 3,122 3,702
Nonco… 1,472 1,536 1,889
inter… 1,220 1,303 1,323
Total 16,742 16,330 17,513
liabi… 7,716 7,988 8,419
and 6,107 5,736 5,383
equity 2,279 2,241 2,473
Suppl… 16,102 15,965 16,275
Balan… Septem… 288 Decem… 54 Septem… 856
Sheet 30, 352 31, 311 30, 382 Table
Infor… 2026 16,742 2025 16,330 2025 17,513 3
──────────────────────────────────────────────────────────────────────────────
Debt
less
cash,
cash $ 6,104 $ 6,593 $ 6,947
equiv…
and
marke…
secur…
Worki…
capit… -6.3 % -7.0 % -4.0 %
% of
sales
Note:
(1) Marketable securities of $85 , $107 and $193 as of September 30, 2026,
December 31, 2025 and September 30, 2025, respectively, are included in Other
current assets.
Colgate-Palmolive Company
Condensed Consolidated Statements
of Cash Flows
For the Nine Months Ended September
30, 2026 and 2025
(Dollars in Millions) (Unaudited)
Operating Activities 2026 2025 Table 4
──────────────────────────────────────────────────────────────────────────────
Net income including noncontrolling $ 2,181 $ 2,266
interests
Adjustments to reconcile net income
including noncontrolling interests
to
net cash provided by operations:
Depreciation and amortization 470 457
ERISA litigation matter — 65
Restructuring and termination
benefits, 177 -15
net of cash
Stock-based compensation expense 141 127
Deferred income taxes 54 8
Cash effects of changes in:
Receivables -224 -180
Inventories -104 9
Accounts payable and other working 254 30
capital
Other non-current assets 48 48
Other non-current liabilities -84 -70
Net cash provided by (used in) 2,913 2,745
operations
Investing Activities
Capital expenditures -400 -387
Purchases of marketable securities
and -163 -537
investments
Proceeds from sale of marketable 187 508
securities and investments
Payment for acquisition, net of
cash — -293
acquired
Other investing activities -5 -5
Net cash provided by (used in)
investing -381 -714
activities
Financing Activities
Short-term borrowing (repayment)
less 947 139
than 90 days, net
Principal payments on debt -1,087 -655
Proceeds from issuance of debt — 497
Dividends paid -1,308 -1,300
Purchases of treasury shares -927 -804
Proceeds from exercise of stock 178 83
options
Other financing activities -75 145
Net cash provided by (used in)
financing -2,272 -1,895
activities
Effect of exchange rate changes on
Cash -21 47
and cash equivalents
Net increase (decrease) in Cash and
cash 239 183
equivalents
Cash and cash equivalents at
beginning 1,288 1,096
of the period
Cash and cash equivalents at end of
the $ 1,527 $ 1,279
period
Supplemental Cash Flow Information
Free cash flow before dividends
(Net
cash provided by operations less
Capital
expenditures)
Net cash provided by operations $ 2,913 $ 2,745
Less: Capital expenditures -400 -387
Free cash flow before dividends $ 2,513 $ 2,358
Income taxes paid $ 648 $ 712
Interest paid $ 205 $ 235
Colg…
Comp…
Segm…
Info…
For
the
Three
and
Nine
Mont…
Ended
Sept…
30,
2026
and
2025
(Dol…
in
Mill…
(Una…
Net
Sales Three Nine
Oral, Mont… Months
Pers… Ended Ended
and Sept… Septe…
Home 30, 30, Table
Care 2026 2025 2026 2025 5
──────────────────────────────────────────────────────────────────────────────
North $ 905 $ 922 $ 2,684 $ 2,745
Amer…
Latin 1,326 1,178 4,011 3,528
Amer…
Euro…
Midd…
East 1,130 1,115 3,377 3,204
&
Afri…
Asia 802 775 2,388 2,259
Paci…
Total
Oral,
Pers… 4,164 3,989 12,4… 11,735
and
Home
Care
Hill…
Pet 1,205 1,142 3,594 3,417
Nutr…
Total
Net $ 5,369 $ 5,131 $ 16,0… $ 15,152
Sales
Three Nine
Mont… Months
Ended Ended
Sept… Septe…
30, 30,
2026 2025 2026 2025
Oper…
Prof…
Oral,
Pers…
and
Home
Care
North $ 177 $ 199 $ 510 $ 583
Amer…
Latin 392 337 1,211 1,052
Amer…
Euro…
Midd…
East 262 243 791 706
&
Afri…
Asia 211 213 643 620
Paci…
Total
Oral,
Pers… 1,042 992 3,155 2,961
and
Home
Care
Hill…
Pet 267 255 816 778
Nutr…
Corp… -221 -189 -902 -523
Total
Oper… $ 1,088 $ 1,059 $ 3,069 $ 3,214
Prof…
Tables may not sum due to rounding.
Notes:
(1) The Company has recast its historical geographic segment information to
conform to the reporting structure effective for the quarter ended March 31,
2026.
(2) Corporate operations include costs related to stock options and restricted
stock units, research and development costs, Corporate overhead costs,
restructuring and related implementation charges and gains and losses on sales
of non-core product lines and assets.
Corporate Operating profit (loss) for the three and nine months ended September
30, 2026 included charges resulting from the Strategic Growth and Productivity
Program of $29 and $327, respectively.
Corporate Operating profit (loss) for the nine months ended September 30, 2025
included charges resulting from the ERISA litigation matter of $15 and
acquisition-related costs of $9.
Ta…
6
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
C…
OF
S…
C…
P…
C…
S… C…
&
C… O… T… F…
… As S… V… I… E…
R… C…
… 4… % 3… % 1… % 2.0 % 1.0 %
…
… -… % -… % -… % 2.2 % -0… %
…
… 1… % 6… % 3… % 2.1 % 6.5 %
…
…
…
… 1… % 2… % 3… % -0… % -1… %
&
…
… 3… % 4… % 1… % 2.8 % -1… %
…
…
… 4… % 3… % 1… % 1.4 % 1.3 %
…
…
… 5… % 5… % 1… % 3.9 % -0… %
…
… 8… % 5… % 3… % 1.7 % 2.7 %
…
… 2… % 2… % 0… % 2.2 % -0… %
…
Table may not sum due to rounding.
Notes:
(1) The Company has recast its historical geographic segment information to
conform to the reporting structure effective for the quarter ended March 31,
2026.
(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the
Middle East and Eastern and Central Europe.
T…
7
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
C…
OF
S…
C…
P…
C…
S… C…
&
C… O… As O… T… F…
R…
… As S… V… V… I… E…
R… C…
… 6… % 3… % … % … % … % … %
…
… -… % -… % … % … % … % … %
…
… 1… % 5… % … % … % … % … %
…
…
…
… 5… % 2… % … % … % … % … %
&
…
… 5… % 5… % … % … % … % … %
…
…
… 6… % 2… % … % … % … % … %
…
…
… 5… % 3… % … % … % … % … %
…
… 1… % 5… % … % … % … % … %
…
… 2… % 1… % … % … % … % … %
…
Table may not sum due to rounding.
Notes:
(1) The impact of the acquisition of the Prime100 pet food business on as
reported volume was 0.2%, 0.8% and 0.3% for Total Company, Hill's Pet Nutrition
and Developed Markets, respectively.
(2) The Company has recast its historical geographic segment information to
conform to the reporting structure effective for the quarter ended March 31,
2026.
(3) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the
Middle East and Eastern and Central Europe.
Table 8
Colgate-Pa…
Company
Non-GAAP
Reconcilia…
For the
Three
Months
Ended
September
30,
2026 and
2025
(Dollars in
Millions
Except Per
Share
Amounts)
(Unaudited)
Gross 2026 2025
Profit
Gross
profit, $ 3,233 $ 3,049
GAAP
Strategic
Growth and 5 —
Productivi…
Program
Gross
profit, $ 3,238 $ 3,049
non-GAAP
Basis Point
Gross
Profit 2026 2025 Change
Margin
Gross
profit 60.2 % 59.4 % 80
margin,
GAAP
Strategic
Growth and 0.1 % — %
Productivi…
Program
Gross
profit 60.3 % 59.4 % 90
margin,
non-GAAP
Selling,
General and 2026 2025
Administra…
Expenses
Selling,
general and
administra… $ 2,111 $ 1,971
expenses,
GAAP
Strategic
Growth and -9 —
Productivi…
Program
Selling,
general and
administra… $ 2,102 $ 1,971
expenses,
non-GAAP
Basis Point
Selling,
General and
Administra…
Expenses as 2026 2025 Change
a
Percentage
of Net
Sales
Selling,
general and
administra…
expenses as
a 39.3 % 38.4 % 90
percentage
of Net
sales,
GAAP
Strategic
Growth and -0.2 % — %
Productivi…
Program
Selling,
general and
administra…
expenses as
a 39.1 % 38.4 % 70
percentage
of Net
sales,
non-GAAP
Other
(Income) 2026 2025
Expense,
Net
Other
(income) $ 34 $ 19
expense,
net, GAAP
Strategic
Growth and -15 —
Productivi…
Program
Other
(income)
expense, $ 19 $ 19
net,
non-GAAP
Operating 2026 2025 % Change
Profit
Operating
profit, $ 1,088 $ 1,059 3 %
GAAP
Strategic
Growth and 29 —
Productivi…
Program
Operating
profit, $ 1,117 $ 1,059 5 %
non-GAAP
Basis Point
Operating
Profit 2026 2025 Change
Margin
Operating
profit 20.3 % 20.6 % -30
margin,
GAAP
Strategic
Growth and 0.5 % — %
Productivi…
Program
Operating
profit 20.8 % 20.6 % 20
margin,
non-GAAP
Non-Service
Related 2026 2025
Postretire…
Costs
Non-service
related $ 24 $ 21
postretire…
costs, GAAP
Strategic
Growth and -1 —
Productivi…
Program
Non-service
related
postretire… $ 23 $ 21
costs,
non-GAAP
Note: The
impact of
non-GAAP
adjustments
may not
necessarily
equal the
difference
between
“GAAP” and
“non-GAAP”
as a
result of
rounding.
…
…
…
…
…
…
…
…
…
…
…
…
…
…
… L… …
… 2… N… I… …
… I… P… I… A… … … …
… B… F… I… to … … … …
… I… I… N… N… … … … 8
… T… T… I… I… … … … …
──────────────────────────────────────────────────────────────────────────────
…
… $ 1… $ 2… $ 7… $ 28 $ 7… 2… % $ 0…
…
…
…
… 30 3 26 — 26 -… % 0…
…
…
… $ 1… $ 2… $ 8… $ 28 $ 7… 2… % $ 0…
The impact of non-GAAP adjustments may not necessarily equal the difference
between “GAAP” and “non-GAAP” as a result of rounding.
Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax
laws and statutory income tax rates applicable in the tax jurisdiction(s) of the
underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents
the difference in the effective tax rate calculated with and without the non-
GAAP adjustment on Income before income taxes and Provision for income taxes.
Table 9
Colgate-P…
Company
Non-GAAP
Reconcili…
For the
Nine
Months
Ended
September
30,
2026 and
2025
(Dollars
in
Millions
Except Per
Share
Amounts)
(Unaudite…
Gross 2026 2025
Profit
Gross
profit, $ 9,755 $ 9,105
GAAP
Strategic
Growth and 7 —
Productiv…
Program
Gross
profit, $ 9,762 $ 9,105
non-GAAP
Selling,
General
and 2026 2025
Administr…
Expenses
Selling,
general
and $ 6,316 $ 5,833
administr…
expenses,
GAAP
Strategic
Growth and -20 —
Productiv…
Program
ERISA
litigation — -15
matter
Selling,
general
and $ 6,296 $ 5,817
administr…
expenses,
non-GAAP
Basis Point
Selling,
General
and
Administr…
Expenses 2026 2025 Change
as a
Percentage
of Net
Sales
Selling,
general
and
administr…
expenses 39.3 % 38.5 % 80
as a
percentage
of Net
sales,
GAAP
Strategic
Growth and -0.1 % — %
Productiv…
Program
ERISA
litigation — % -0.1 %
matter
Selling,
general
and
administr…
expenses 39.2 % 38.4 % 80
as a
percentage
of Net
sales,
non-GAAP
Other
(Income) 2026 2025
Expense,
Net
Other
(income) $ 370 $ 58
expense,
net, GAAP
Strategic
Growth and -300 —
Productiv…
Program
Acquisiti… — -9
costs
Other
(income)
expense, $ 70 $ 48
net,
non-GAAP
Operating 2026 2025 % Change
Profit
Operating
profit, $ 3,069 $ 3,214 -5 %
GAAP
Strategic
Growth and 327 —
Productiv…
Program
ERISA
litigation — 15
matter
Acquisiti… — 9
costs
Operating
profit, $ 3,396 $ 3,240 5 %
non-GAAP
Basis Point
Operating
Profit 2026 2025 Change
Margin
Operating
profit 19.1 % 21.2 % -210
margin,
GAAP
Strategic
Growth and 2.1 % — %
Productiv…
Program
ERISA
litigation — % 0.1 %
matter
Acquisiti… — % 0.1 %
costs
Operating
profit 21.2 % 21.4 % -20
margin,
non-GAAP
Non-Servi…
Related 2026 2025
Postretir…
Costs
Non-servi…
related
postretir… $ 70 $ 116
costs,
GAAP
Strategic
Growth and -6 —
Productiv…
Program
ERISA
litigation — -50
matter
Non-servi…
related
postretir… $ 64 $ 66
costs,
non-GAAP
Note: The
impact of
non-GAAP
adjustmen…
may not
necessari…
equal the
difference
between
“GAAP” and
“non-GAAP”
as a
result of
rounding.
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
… L… …
… 2… N… I… …
… I… P… I… A… … … …
… B… F… I… to … … … …
… I… I… N… N… … … … 9
… T… T… I… I… … … … …
──────────────────────────────────────────────────────────────────────────────
…
… $ 2… $ 6… $ 2… $ 91 $ 2… 2… % $ 2…
…
…
…
… 3… 64 2… 1 2… -… % 0…
…
…
… $ 3… $ 7… $ 2… $ 91 $ 2… 2… % $ 2…
2…
N… L… …
I… P… I… I… … … …
B… F… I… A… … … …
I… I… N… to … … …
T… T… I… N… … … …
I… …
…
… $ 2… $ 6… $ 2… $ 97 $ 2… 2… % $ 2…
…
…
… 65 12 53 — 53 — % 0…
…
… 9 2 7 — 7 — % 0…
…
… $ 3… $ 7… $ 2… $ 97 $ 2… 2… % $ 2…
The impact of non-GAAP adjustments may not necessarily equal the difference
between “GAAP” and “non-GAAP” as a result of rounding.
Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax
laws and statutory income tax rates applicable in the tax jurisdiction(s) of the
underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents
the difference in the effective tax rate calculated with and without the non-
GAAP adjustment on Income before income taxes and Provision for income taxes.